Evidence map›Paper›PMID 40351997›Full record

ArticleCureus2025

A Case Report of Xanthelasma and the Associated Differential Diagnosis.

Braden Van Alfen, Jonny Hatch, Mark Conley, Sathishkumar Seeliyur Duraiswamy

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Braden Van AlfenTexas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, USA.
Jonny HatchDermatology Residency Program, Trinity Health Ann Arbor Hospital, Ypsilanti, USA.
Mark ConleyTexas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, USA.
Sathishkumar Seeliyur DuraiswamyHospital Medicine, Baylor All Saints Medical Center, Fort Worth, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xanthelasma, also known as xanthelasma palpebrarum, is a harmless, soft yellow plaque on or near the eyelids. A significant proportion of patients with xanthelasma have an underlying disease causing hyperlipidemia and should be evaluated for underlying causes. A 61-year-old woman presented to the emergency room for abdominal pain and lower extremity edema for two weeks. On physical exam, the patient was jaundiced with scleral icterus and asymptomatic bilateral yellow plaques on the medial aspect of the upper eyelids. The patient had a history of primary biliary cholangitis (PBC), and previous lab results were positive for anti-mitochondrial antibodies and Anti-smooth muscle antibodies. The patient's history and presentation were sufficient for the diagnosis of xanthelasma.  This case report describes an interesting case of xanthelasma and details the differential diagnosis that should be considered. The differential diagnosis includes necrobiotic xanthogranuloma, Erdheim-Chester disease, lipoid proteinosis, palpebral sarcoidosis, syringoma, sebaceous hyperplasia, and nodular basal cell carcinoma. Although xanthelasma can be easily diagnosed in some cases, other conditions on the differential should be considered to avoid delay in patient care.

Indexed as

erdheim–chester diseaselipoid proteinosis (lp)necrobiotic xanthogranulomaocular sarcoidosisprimary biliary cholangitis (pbc)xanthelasma

Identifiers

PMID40351997
PMCPMC12064078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.